Advertisement

Infection

, Volume 42, Issue 2, pp 309–316 | Cite as

Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis

  • C. Lübbert
  • D. Becker-Rux
  • A. C. Rodloff
  • S. Laudi
  • T. Busch
  • M. Bartels
  • U. X. Kaisers
Clinical and Epidemiological Study

Abstract

Purpose

From mid-2010 to early 2013 there was a large single-center (Leipzig University Hospital, Germany) outbreak of Klebsiella pneumoniae carbapenemase (KPC) type 2 producing K. pneumoniae (KPC-2-KP) involving a total of 103 patients. The aim of this study was to compare KPC-positive liver transplant recipients (LTR) and KPC-negative controls to determine both the relative risk of infection following colonization with KPC-2-KP and the case fatality rate associated with KPC-2-KP.

Methods

The study cohort of this retrospective observational study comprised nine patients who had undergone orthotopic liver transplantation (LTx) (median age of 52 years, range 28–73 years) with confirmed evidence of colonization with KPC-2-KP. The data from these nine LTR were matched to 18 LTR (1:2) in whom carbapenem-resistant pathogens were not present and compared for clinical outcomes.

Results

Of these nine cases, eight (89 %) progressed to infection due to KPC-2-KP, and five (56 %) were confirmed to have bloodstream infection with KPC-2-KP. Matched-pair analysis of KPC-positive LTR and KPC-negative controls revealed a substantially increased relative risk of 7.0 (95 % confidence interval 1.8–27.1) for fatal infection with KPC-2-producing K. pneumoniae after transplantation with a mortality rate of 78 % (vs. 11 %, p = 0.001).

Conclusions

Colonization with KPC-2-KP in LTR leads to high infection rates and excess mortality. Therefore, frequent screening for carbapenem-resistant bacteria in patients on LTx waiting lists appears to be mandatory in an outbreak setting. Patients with evidence of persistent colonization with KPC-producing pathogens should be evaluated with extreme caution for LTx.

Keywords

Klebsiella pneumoniae carbapenemase KPC-producing Klebsiella pneumoniae Carbapenem resistance Liver transplant recipients Mortality 

Notes

Acknowledgments

The authors would like to thank Joachim Mössner, MD, PhD (Professor and Chair, Department of Gastroenterology and Rheumatology) and Wolfgang Fleig, MD, PhD (Professor of Medicine, Medical Chairman and Chairman of the Board), both Leipzig University Hospital, Germany, for their assistance.

Conflict of interest

All authors deny any potential conflicts of interest, including relevant financial interests, activities, relationships, and affiliations (other than those affiliations listed in the title page) relevant to the subject of this manuscript.

References

  1. 1.
    Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36.PubMedCrossRefGoogle Scholar
  2. 2.
    Linares L, Cervera C, Hoyo I, Sanclemente G, Marco F, Cofán F, et al. Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance. Transplant Proc. 2010;42:2941–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099–106.PubMedCrossRefGoogle Scholar
  4. 4.
    Mlynarczyk G, Kosykowska E, de Walthoffen SW, Szymanek-Majchrzak K, Sawicka-Grzelak A, Baczkowska T, et al. A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients. Transplant Proc. 2011;43:3135–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, Cipullo R, Moreira JC, Baia C, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis. 2012;14:198–205.PubMedCrossRefGoogle Scholar
  6. 6.
    Snitkin ES, Zelazny AM, Thomas PJ, Stock F, NISC Comparative Sequencing Program Group, Henderson DK, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4:148ra116.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, et al. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012;14:229–36.PubMedCrossRefGoogle Scholar
  8. 8.
    Kaase M. Zur aktuellen Situation bei Carbapenemase-bildenden gramnegativen Bakterien in Deutschland. Epid Bull. 2013;19:167–71.Google Scholar
  9. 9.
    Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, et al. Bloodstream infections caused by metallo-b-lactamase/Klebsiella pneumonia carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol. 2010;31:1250–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18:54–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Sbrana F, Malacarne P, Viaggi B, Costanzo S, Leonetti P, Leonildi A, et al. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit. Clin Infect Dis. 2013;56:697–700.PubMedCrossRefGoogle Scholar
  12. 12.
    Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol. 2012;33:14–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Orsi GB, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection. 2013;41:61–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Kalpoe JS, Sonnenberg E, Factor SH, del Rio Martin J, Schiano T, Patel G, Huprikar S. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant. 2012;18:68–74.CrossRefGoogle Scholar
  15. 15.
    Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Lübbert C, Faucheux S, Becker-Rux D, Laudi S, Dürrbeck A, Busch T, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013. doi: 10.1016/j.ijantimicag.2013.08.008. Accessed 12 Oct 2013.PubMedGoogle Scholar
  17. 17.
    Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–96.PubMedCrossRefGoogle Scholar
  18. 18.
    Wendt C, Schütt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis. 2010;29:563–70.PubMedCrossRefGoogle Scholar
  19. 19.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0. 2012. Available at: http://www.eucast.org. Accessed 12 Oct 2013.
  20. 20.
    ISO (International Organization for Standardization). Clinical laboratory testing and in vitro diagnostic test systems––susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices-part 1. Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. 2010. Available at: http://www.iso.org. Accessed 12 Oct 2013.
  21. 21.
    Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Singh K, Mangold KA, Wyant K, Schora DM, Voss B, Kaul KL, et al. Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol. 2012;50:2596–600.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56:2108–13.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect. 2011;17:1135–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • C. Lübbert
    • 1
  • D. Becker-Rux
    • 2
  • A. C. Rodloff
    • 3
  • S. Laudi
    • 2
  • T. Busch
    • 2
  • M. Bartels
    • 4
  • U. X. Kaisers
    • 2
  1. 1.Division of Infectious Diseases and Tropical Medicine, Department of Gastroenterology and RheumatologyLeipzig University HospitalLeipzigGermany
  2. 2.Department of Anaesthesiology and Intensive Care MedicineLeipzig University HospitalLeipzigGermany
  3. 3.Institute for Medical Microbiology and Epidemiology of Infectious DiseasesLeipzig University HospitalLeipzigGermany
  4. 4.Department of Visceral, Transplant, Thoracic and Vascular SurgeryLeipzig University HospitalLeipzigGermany

Personalised recommendations